Skip to content

4Accepted Sep 15, 4:51 PM ET

Zedge (ZDGE) Director Elliot Gibber Buys 221,843 Class B Shares & Warrants

ZDGEZedge, Inc.

Accepted (ET)

4:51 PM

Sep 15, 2026

Filed

Sep 15, 2026

Documents

1

Size

7.5 KB

Summary

Zedge (ZDGE) Director Elliot Gibber Buys 221,843 Class B Shares & Warrants

Updated

What Happened
Elliot Gibber, a director of Zedge, acquired 221,843 Class B shares in a private placement on 2026-09-11 at $2.93 per share (about $650,000). In connection with that purchase he also received warrants to buy 199,659 Class B shares (90% of the shares purchased). The warrants have a $3.22 exercise price, become exercisable no earlier than the later of six months after closing or shareholder approval, and expire on September 10, 2036. This transaction was a purchase (a bullish signal relative to sales, though not a guarantee).

Key Details

  • Transaction date: 2026-09-11 (reported on Form 4 filed 2026-09-15). Transaction code: P (purchase); the 199,659 entry is recorded as a derivative (warrants).
  • Price and value: $2.93 per Class B share; 221,843 shares × $2.93 ≈ $650,000 cash paid. Warrants exercise price = $3.22/share.
  • Shares/warrants owned after transaction: 461,952 total common shares (120,917 vested restricted shares + 341,035 held directly, of which 221,843 were just purchased) and 199,659 warrants.
  • Footnotes: (F1) Shares and warrants were purchased together in a private placement; warrants equal 90% of shares bought and expire 9/10/2036. (F2) Breakdown of holdings after the deal.
  • Filing timeliness: Form 4 was filed four days after the transaction date (reported 9/15 for a 9/11 trade), which appears later than the SEC’s typical 2-business-day reporting requirement.

Context

  • The derivative portion represents warrants (not immediate stock). Warrants cannot be exercised until the vesting/exercise conditions are met (six-month delay and/or shareholder approval), so any additional share dilution or exercise-related purchases would occur later if/when exercised.
  • Purchases by directors are generally considered more informative than routine sales, but they do not guarantee future stock performance.

AI-written summary · check the filing